Does UPADACITINIB Cause Peripheral swelling? 1,455 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,455 reports of Peripheral swelling have been filed in association with UPADACITINIB (Rinvoq). This represents 2.2% of all adverse event reports for UPADACITINIB.
1,455
Reports of Peripheral swelling with UPADACITINIB
2.2%
of all UPADACITINIB reports
88
Deaths
420
Hospitalizations
How Dangerous Is Peripheral swelling From UPADACITINIB?
Of the 1,455 reports, 88 (6.0%) resulted in death, 420 (28.9%) required hospitalization, and 93 (6.4%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,455 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which UPADACITINIB Alternatives Have Lower Peripheral swelling Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL